Hoth Therapeutics, Inc. (HOTH)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.7565 |
| Open | 0.7330 |
| Bid | 0.7158 x 100 |
| Ask | 0.7949 x 100 |
| Day's range | 0.7330 - 0.7600 |
| 52-week range | 0.5800 - 1.7300 |
| Volume | |
| Avg. volume | 3,724,189 |
| Market cap | 5.185M |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Hoth Stock Up as Lead Drug Heals Skin Toxicities in Cancer Patient
HOTH stock soars on superior efficacy data from the first patient treated with the lead candidate, HT-001, suffering from EGFRI-related skin toxicities.
- Zacks
Hoth Therapeutics (HOTH) Up on Upbeat Alzheimer's Drug Data
Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.
© 2024 Yahoo. All rights reserved.